Compounds > lofexidine
Page last updated: 2024-08-23

lofexidine and Recrudescence

lofexidine has been researched along with Recrudescence in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Baker, N; Brady, K; Cortese, B; Guille, C; King, C; McRae-Clark, A; Nunn, L; Ramakrishnan, V; Rogers, T1
Fogelman, N; Hermes, G; Hyman, SM; Kosten, TR; Sinha, R1
Bearn, J; Best, D; Beswick, T; Gossop, M; McCambridge, J; Rees, S; Strang, J1

Trials

3 trial(s) available for lofexidine and Recrudescence

ArticleYear
The impact of lofexidine on stress-related opioid craving and relapse: Design and methodology of a randomized clinical trial.
    Contemporary clinical trials, 2021, Volume: 111

    Topics: Analgesics, Opioid; Clonidine; COVID-19; Craving; Humans; Hypothalamo-Hypophyseal System; Pandemics; Pituitary-Adrenal System; Recurrence; SARS-CoV-2

2021
Lofexidine in Combination With Oral Naltrexone for Opioid Use Disorder Relapse Prevention: A Pilot Randomized, Double-Blind, Placebo-Controlled Study.
    The American journal on addictions, 2019, Volume: 28, Issue:6

    Topics: Administration, Oral; Adolescent; Adult; Chemoprevention; Clonidine; Craving; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Intention to Treat Analysis; Male; Medication Adherence; Middle Aged; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Patient Compliance; Pilot Projects; Recurrence; Secondary Prevention; Substance Withdrawal Syndrome; Treatment Outcome; Young Adult

2019
In-patient detoxification procedures, treatment retention, and post-treatment opiate use: comparison of lofexidine + naloxone, lofexidine + placebo, and methadone.
    Drug and alcohol dependence, 2007, Apr-17, Volume: 88, Issue:1

    Topics: Adolescent; Adrenergic alpha-Agonists; Adult; Analgesics, Opioid; Clonidine; Cohort Studies; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Length of Stay; Male; Methadone; Middle Aged; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Recurrence; Substance Abuse Treatment Centers; Substance Withdrawal Syndrome; Treatment Outcome

2007